Chemoresistance of human monocyte-derived dendritic cells is regulated by IL-17A.

Dendritic cells initiate adaptive immune responses, leading either to control cancer by effector T cells or to exacerbate cancer by regulatory T cells that inhibit IFN-γ-mediated Th1-type response. Dendritic cells can also induce Th17-type immunity, mediated by IL-17A. However, the controversial rol...

Full description

Bibliographic Details
Main Authors: Selma Olsson Åkefeldt, Carine Maisse, Alexandre Belot, Marlène Mazzorana, Giulia Salvatore, Nathalie Bissay, Pierre Jurdic, Maurizio Aricò, Chantal Rabourdin-Combe, Jan-Inge Henter, Christine Delprat
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3575476?pdf=render